| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gain Therapeutics, Inc. | Director | Stock Option (right to buy) | 15K | $87.9K | $5.86 | Jun 24, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GANX | Gain Therapeutics, Inc. | Jun 24, 2025 | 1 | $0 | 4 | Jun 25, 2025 | Director |
| GANX | Gain Therapeutics, Inc. | Jun 24, 2024 | 1 | $0 | 4 | Jun 26, 2024 | Director |
| GANX | Gain Therapeutics, Inc. | Mar 28, 2024 | 1 | $116K | 4 | Apr 1, 2024 | Director |
| GANX | Gain Therapeutics, Inc. | Jun 23, 2023 | 1 | $0 | 4 | Jun 26, 2023 | Director |
| GANX | Gain Therapeutics, Inc. | Sep 20, 2022 | 1 | $0 | 4 | Sep 22, 2022 | Director |